FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
Silver Hammer Announces Uplisting to the OTCQB Venture Market in the United States, and Receives DTC Eligibility
